Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Henry Meds vs NuvaHealth

Henry Meds
Graded #46

Higher grade

vs+3.0999999999999943
NuvaHealth
Graded #65

Lower grade

The verdict

Henry Meds takes it — 77.3/100 to 74.2/100.

Henry Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A flat-fee compounded pioneer — simple, but priced at the higher end of the board now.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNuvaHealth +4
72
76
Dose & formulationNuvaHealth +8
80
88
Clinical oversightNuvaHealth +2
80
82
Labs & monitoringHenry Meds +25
78
53
FulfillmentHenry Meds +4
78
74
Contract termsHenry Meds +23
78
55
Henry Meds · left barNuvaHealth · right bar

The numbers

MetricHenry MedsNuvaHealth
WeighScore77.3/10074.2/100
GradeC+C
Scorecard rank#46#65
Semaglutide$249/mo$139/mo (first-month rate, compounded)
Tirzepatide$349/mo$229/mo (first-month rate, compounded)
CoverageMulti-stateCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Henry Meds

Graded #46 · C+

Strengths

  • Simple flat-fee model
  • Established brand
  • Both molecules

Where it loses points

  • Higher pricing than newer entrants
  • Compounded only
NuvaHealth

Graded #65 · C

Strengths

  • LegitScript Certified seal displayed on the marketing site (the standard third-party telehealth/pharmacy accreditation)
  • Free and fast delivery + 24/7 patient support disclosed on the home page
  • Newark, DE address suggests a US-incorporated entity (vs offshore)
  • $139 first-month price for compounded semaglutide injection is among the cheapest in the US compounded telehealth market
  • $229 first-month price for compounded tirzepatide injection sits in the lower-median range

Where it loses points

  • Standard ongoing monthly price NOT publicly disclosed (gated behind checkout) — patients should ask for the maintenance-dose price before committing
  • Specific legal entity name + state of incorporation NOT publicly disclosed on the home page — material YMYL transparency gap
  • Pharmacy partners NOT publicly named — material YMYL transparency gap
  • Per-state availability NOT enumerated; verify your state ships before purchase
  • Lab work + coaching support NOT publicly disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard